Trials of aliskiren for CAD and otamixaban for NSTE-ACS, chronic care management for substance dependence, and more.

Editor's Audio Summary by Phil B. Fontanarosa, MD, MBA, Executive Editor, the Journal of the American Medical Association, for the September 18, 2013 issue

Episode metadata supplied by the publisher feed · Published Sep 17, 2013

Embed this episode

Attribution link and audio player

Ready to play

Trials of aliskiren for CAD and otamixaban for NSTE-ACS, chronic care management for substance dependence, and more.

0:00 13:34

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of JAMA Editors' Summary?

This episode is 13 minutes long.

When was this JAMA Editors' Summary episode published?

This episode was published on September 17, 2013.

Can I download this JAMA Editors' Summary episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!